183 related articles for article (PubMed ID: 34089806)
1. Digital PCR detection of EGFR somatic mutations in non-small-cell lung cancer formalin fixed paraffin embedded samples.
Carvalho TM; Dourado RM; Nakatani SM; Barros Duarte CA; Ioshii SO; Riediger IN; Tuon FF; Winter Boldt AB
Mol Cell Probes; 2021 Aug; 58():101745. PubMed ID: 34089806
[TBL] [Abstract][Full Text] [Related]
2. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
[TBL] [Abstract][Full Text] [Related]
3. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S
BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958
[TBL] [Abstract][Full Text] [Related]
4. The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.
Yang Y; Shen X; Li R; Shen J; Zhang H; Yu L; Liu B; Wang L
Oncotarget; 2017 Jul; 8(30):49773-49782. PubMed ID: 28572536
[TBL] [Abstract][Full Text] [Related]
5. Increase EGFR Mutations Detection Rate in Lung Adenocarcinoma by Real-Time PCR Screening Followed by Direct Sequencing.
Er TK; Lin CW; Liu TC; Chen CC; Wang LH; Hsieh LL; Tsai WC
Appl Immunohistochem Mol Morphol; 2015; 23(5):343-8. PubMed ID: 25961746
[TBL] [Abstract][Full Text] [Related]
6. Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer.
Masago K; Fujita S; Hata A; Okuda C; Yoshizumi Y; Kaji R; Katakami N; Hirata Y; Yatabe Y
Pathol Int; 2018 Mar; 68(3):167-173. PubMed ID: 29341374
[TBL] [Abstract][Full Text] [Related]
7. Detection of EGFR somatic mutations in non-small cell lung cancer (NSCLC) using a novel mutant-enriched liquidchip (MEL) technology.
Zhang L; Yang H; Zhao Y; Liu W; Wu S; He J; Luo X; Zhu Z; Xu J; Zhou Q; Ren-Heidenreich L
Curr Drug Metab; 2012 Sep; 13(7):1007-11. PubMed ID: 22591345
[TBL] [Abstract][Full Text] [Related]
8. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific PCR method for identification of EGFR mutations in non-small cell lung cancer: formalin-fixed paraffin-embedded tissue versus fresh tissue.
Suciu BA; Pap Z; Dénes L; Brînzaniuc K; Copotoiu C; Pávai Z
Rom J Morphol Embryol; 2016; 57(2):495-500. PubMed ID: 27516024
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
[TBL] [Abstract][Full Text] [Related]
11. Detection of epidermal growth factor receptor mutations in formalin fixed paraffin embedded biopsies in Malaysian non-small cell lung cancer patients.
Shi Yeen TN; Pathmanathan R; Shiran MS; Ahmad Zaid FA; Cheah YK
J Biomed Sci; 2013 Apr; 20(1):22. PubMed ID: 23590575
[TBL] [Abstract][Full Text] [Related]
12. [Detection of EGFR gene mutations in 100 non-small cell lung cancer clinical samples by a real-time polymerase chain reaction method using amplification refractory mutation system specific primers and Taqman fluorescence probes].
Zhao J; Zhao J; Zhao X; Chen W; Zhong W; Zhang L; Li L; Wang M
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):25-32. PubMed ID: 23327870
[TBL] [Abstract][Full Text] [Related]
13. Detection of EGFR mutations by TaqMan mutation detection assays powered by competitive allele-specific TaqMan PCR technology.
Roma C; Esposito C; Rachiglio AM; Pasquale R; Iannaccone A; Chicchinelli N; Franco R; Mancini R; Pisconti S; De Luca A; Botti G; Morabito A; Normanno N
Biomed Res Int; 2013; 2013():385087. PubMed ID: 24364033
[TBL] [Abstract][Full Text] [Related]
14. [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing].
Zhang HP; Ruan L; Zheng LM; Bai DY; Zhang HF; Liao YQ; Ding Y
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):28-32. PubMed ID: 23648296
[TBL] [Abstract][Full Text] [Related]
15. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
[TBL] [Abstract][Full Text] [Related]
16. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
Kim HJ; Lee KY; Kim YC; Kim KS; Lee SY; Jang TW; Lee MK; Shin KC; Lee GH; Lee JC; Lee JE; Kim SY
Lung Cancer; 2012 Mar; 75(3):321-5. PubMed ID: 21930325
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
[TBL] [Abstract][Full Text] [Related]
18. Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer.
Akkhasutthikun P; Kaewsapsak P; Nimsamer P; Klomkliew P; Visedthorn S; Chanchaem P; Teerapakpinyo C; Payungporn S; Luangdilok S
Cancer Res Treat; 2024 Apr; 56(2):455-463. PubMed ID: 37986562
[TBL] [Abstract][Full Text] [Related]
19. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
[TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of T790M mutations in lung cancer biopsies using a PCR-based lateral flow assay.
Dong N; Wang W; Lin S
Anal Biochem; 2022 Jan; 637():114476. PubMed ID: 34800430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
